A Framework to Evaluate the Cost-Effectiveness of the NADiA ProsVue Slope to Guide Adjuvant Radiotherapy among Men with High-Risk Characteristics Following Prostatectomy for Prostate Cancer-Reference-Cited by-同舟云学术

A Framework to Evaluate the Cost-Effectiveness of the NADiA ProsVue Slope to Guide Adjuvant Radiotherapy among Men with High-Risk Characteristics Following Prostatectomy for Prostate Cancer

Published:2014-07 Issue:5 Volume:17 Page:545-554
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Reed Shelby D.,Stewart Suzanne Biehn,Scales Charles D.,Moul Judd W.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference37 articles.

1. Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007;Dinan;Int J Radiat Oncol Biol Phys,2012

2. Pathologic findings at radical prostatectomy: risk factors for failure and death;Swanson;Urol Oncol,2007

3. Correlation of pathologic findings with progression after radical retropubic prostatectomy;Epstein;Cancer,1993

4. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term follow up of a randomized clinical trial;Thompson;J Urol,2009

5. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95;Wiegel;J Clin Oncol,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health Economic Evidence for Liquid- and Tissue-based Molecular Tests that Inform Decisions on Prostate Biopsies and Treatment of Localised Prostate Cancer: A Systematic Review;European Urology Open Science;2021-05

2. Optimizing the risk threshold of lymph node involvement for performing extended pelvic lymph node dissection in prostate cancer patients: a cost-effectiveness analysis;Urologic Oncology: Seminars and Original Investigations;2021-01

3. Decision Support Systems in Prostate Cancer Treatment: An Overview;BioMed Research International;2019-06-06

4. What Can Be Expected from Prostate Cancer Biomarkers A Clinical Perspective;Urologia Internationalis;2017-09-15

5. Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate Cancer;Clinical Genitourinary Cancer;2017-06